The Ottawa Hospital Research Institute

Ottawa K1H 8L6

1 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, End Stage Kidney Disease, Intracranial Hemorrhages, Multiple Sclerosis

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) — Running, not enrolling
• Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis — Status unconfirmed